145 related articles for article (PubMed ID: 5323383)
1. [Critical observations on the pharmacotherapy of arterial circulation disorders of the extremities].
Linke H
Dtsch Gesundheitsw; 1965 Aug; 20(33):1505-16. PubMed ID: 5323383
[No Abstract] [Full Text] [Related]
2. [Clinical trial of fenoxedil in peripheral artery diseases].
Warembourg H; Thery C
Lille Med; 1976 Jan; 21(1 suppl 1):4-7. PubMed ID: 1256230
[No Abstract] [Full Text] [Related]
3. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
Myers KA
Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885
[No Abstract] [Full Text] [Related]
4. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
Hild R
Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
[No Abstract] [Full Text] [Related]
5. [Kinesitherapy of organic diseases of the arteries of the extremities].
Kozák P
Cas Lek Cesk; 1967 Sep; 106(39):1036-9. PubMed ID: 6055868
[No Abstract] [Full Text] [Related]
6. [Letter: So-called vasodilator agents in conservative vascular therapy].
Fischer H
Hautarzt; 1975 Feb; 26(2):108-9. PubMed ID: 1126839
[No Abstract] [Full Text] [Related]
7. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
Baitsch G; Schäfer M
Med Welt; 1969 Aug; 35():1910-3. PubMed ID: 4897422
[No Abstract] [Full Text] [Related]
8. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
Hamming JJ; van der Drift JH
Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
[No Abstract] [Full Text] [Related]
9. The use and abuse of vasodilator drugs.
Rose SS
Vasc Dis; 1967 Apr; 4(2):67-82. PubMed ID: 6027150
[No Abstract] [Full Text] [Related]
10. [Drug therapy of peripheral arterial blood circulation disorders].
Bollinger A
Dtsch Med Wochenschr; 1969 Nov; 94(45):2347-9. PubMed ID: 5346859
[No Abstract] [Full Text] [Related]
11. [On the conservative treatment of peripheral arterial circulatory disorders].
Köhler M
Med Klin; 1969; 64(35):1536-40. PubMed ID: 5354487
[No Abstract] [Full Text] [Related]
12. Effects of nitrites on arterial collateral vessels of dogs.
Iriuchijima J
Jpn Heart J; 1971 Nov; 12(6):536-44. PubMed ID: 5003256
[No Abstract] [Full Text] [Related]
13. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
Bollinger A; Lüthy E
Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
[No Abstract] [Full Text] [Related]
14. [Conservative therapy of arterial occlusive diseases on a rational basis].
Alexander K
Dtsch Med J; 1972 May; 23(5):343-8. PubMed ID: 5036945
[No Abstract] [Full Text] [Related]
15. Controlled evaluation of drugs in chronic vascular disease.
Trübestein G
Angiology; 1981 Oct; 32(10):699-704. PubMed ID: 6173001
[No Abstract] [Full Text] [Related]
16. [Experience with Complamin in peripheral circulation disorders].
Wittenburg H
Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
[No Abstract] [Full Text] [Related]
17. [Therapy of peripheral circulation disorders. Double-blind study on the effect of fludilat].
König FK
Med Welt; 1972 May; 23(20):763-8. PubMed ID: 5037194
[No Abstract] [Full Text] [Related]
18. Paniverine of a new type for the management of obliterative arterial diseases.
Bugár-Mészáros K; Fonó J
Ther Hung; 1965; 13(4):151-5. PubMed ID: 5864163
[No Abstract] [Full Text] [Related]
19. [Current problems in the pharmacotherapy of vascular diseases].
Cahn J
Minerva Med; 1976 May; 67(25):1621-7. PubMed ID: 934517
[No Abstract] [Full Text] [Related]
20. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Lehrach F; Müller R
Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
